![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1480-1481, 2005-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab has an impact on psoriatic arthritis QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 501, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Psoriasis associated with psoriatic arthritis: case report
Reactions Weekly, Vol. 1, Iss. 1411, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab: In Psoriatic Arthritis
By Simpson Dene Scott Lesley J.
Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. :